Presenting the most compelling new finds from the Ascendient Research Team ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­    ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  
View in browser
HCRR Aug 2026

Looking for Even More Research?

 

In case you missed it, Ascendient recently introduced a second monthly version of Research Roundup, this one focused on helping leaders understand and apply the latest studies in public health.

 

That means you won’t be seeing specific public health sources in this brief anymore – and not because the subject is unimportant. Just the opposite, in fact. As we’ve been saying for a while, we see increasingly blurry lines between healthcare and public health, and we believe that convergence is necessary to bring costs under control while building healthier communities.

 

We suspect the public health studies will be missed, based on their high readership, so please take a moment to sign up for your free subscription to the new Public Health Research Roundup. (No one will be opted in automatically because we respect your privacy – and your inbox.)

 

Now, on to this month’s must-read healthcare studies, including yet another emerging use case for GLP-1 drugs. We’ve noticed those studies popping up frequently, so we tried to connect the dots in a recent blog post. Spoiler alert: We see significant impacts ranging from bed planning to ED utilization.

 

HEALTH TRENDS G

CDC Flags Soaring Cases of Gestational Hypertension

A new National Vital Statistics Report from the CDC found that 1 in 10 U.S. births in 2024 involved a gestational hypertension diagnosis, up 73% since 2016. Rates rose across every race and Hispanic-origin group, age bracket, BMI category, and plurality, including a steeper rise for singleton births (76%) than multiple births (37%). Our Take: With growing evidence linking these disorders to higher lifetime cardiovascular risk, such a sharp rise in gestational hypertension calls for a range of responses, starting with updated training from med school through community practice. Follow-up also deserves more attention, including better information for EDs and EMS, because hypertensive emergencies can strike weeks postpartum. – Laura Armstrong-Bauer

WORKFORCE G

NPs Emerge as Key Workforce Solution 

A new Health Affairs analysis projects the nurse practitioner (NP) workforce will grow 11% annually through 2030 – roughly ten times the projected physician growth rate. That trajectory continues the trend identified in a July 2026 Sheps Center analysis, which found that NP and PA staffing per system bed rose 66.7% between 2018 and 2023. Our Take: Physician supply isn't catching up with demand; the math hasn't worked for years. The organizations already ahead of this have built onboarding, supervision, and scope-of-practice policies that let NPs and PAs practice to the top of their license. Others need to start now, because this gap isn't closing on its own. – Miranda Pack

DELIVERY G

GLP-1s Show Early Promise in Spinal Surgery

A new propensity-matched cohort study in The Spine Journal found that patients on GLP-1 receptor agonists undergoing anterior cervical discectomy and fusion (ACDF) had fewer complications than those not on the medication. GLP-1 users were less likely to have acute kidney injury (0.94% vs. 1.69%) or an extended hospital stay of three or more days (15.96% vs. 18.65% of patients), with no rise in aspiration risk despite the slowed gastric emptying. Our Take: A low-cost move for high-volume spine programs is to capture GLP-1 status at pre-op intake and build it into ACDF risk stratification. Findings vary across studies, so track outcomes as more data emerges. – Patricia Dowbiggin

TECH G

Patient Messaging Creates Unpaid Work for Providers

A recent study found that just 5% of patients generate 53% of all patient portal messages, while primary care physicians in the top quartile of inbound message volume received 5x more messages than the median physician. This creates unpaid labor as top-quartile physicians log roughly 2 (and up to 5) additional EHR hours per week. Physicians with higher in-person visits received fewer messages per visit, undercutting the case for raising visit fees to cover messaging work. Our Take: To combat uncompensated EHR work, health system leaders should route high-volume messaging to nursing teams rather than physicians and pay for clinically complex messages through e-visit codes instead of higher visit rates. – Aaron Hayes

FINANCES G

State-Directed Payments: a $60B Problem for 2028?

A new KFF analysis found that up to $60 billion may be at risk under a 2025 reconciliation law that limits Medicaid state-directed payments (SDPs). Many states previously set SDPs near commercial insurance rates, but federal caps will now cap such payments at or near Medicare rates. About $30 billion in excess spending is concentrated in just 8 states (AZ, CA, IL, LA, KY, MI, NC, and TX), with 29 others exceeding caps to a lesser extent. Our Take: If you haven't already modeled your SDP exposure, this breakdown offers a place to start. In high-impact states, it's worth checking assumptions against these figures before sharing at the next board-level financial briefing. – Robert Jones

 

Do you have a colleague who would enjoy reading our monthly Research Roundup? Please forward this issue and urge them to subscribe!

Ascendient, 1335 Environ Way, Chapel Hill, NC 27517, 919-403-3300

Unsubscribe Manage preferences